RI-MUHC researchers work to accelerate precision medicine for cancer in Canada
Three additional RI-MUHC research projects funded by the Marathon of Hope Cancer Centres Network
Congratulations to our 2024 CLIC winners and finalists
RI-MUHC researchers and trainees collaborate on four winning teams
RI-MUHC study uses AI to understand liver cancer
A new publication describes the use of ALiX, a unique AI model, to analyze data from liquid biopsy
Annual Clinical Research Day event highlights RI-MUHC services and expertise in clinical trials
The Centre for Innovative Medicine and many other clinical research support teams introduced their skills...
Two RI-MUHC researchers receive funding from the Marathon of Hope Cancer Centres Network
Morag Park, Ph.D. and George Zogopoulos, MD., Ph.D., are two of the four beneficiaries of the Pan-Canadian...
Lucy Gilbert honoured for publication in Gynecologic Oncology
The most cited publication and one of the journal’s most read in 2023
Earth Day 2024 at the RI-MUHC: Towards greater sustainability
Organization-wide teamwork is reducing the environmental footprint of research
New findings illustrate pathway for screening high-risk individuals for pancreatic cancer
An international collaboration of scientists and healthcare professionals is developing a promising surveillance...
A new hope for men with metastatic prostate cancer
MUHC patients are the first enrolled in a new global Phase 1 clinical trial testing Actinium-225, a therapeutic agent used in nuclear precision medicine
An opportunity to learn, celebrate and connect during Black History Month at the RI-MUHC
An expert panel explored Equity, Diversity and Inclusion in research and healthcare